LEAP THERAPEUTICS, INC. Annual Depreciation in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Leap Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2016 to 2023.
  • Leap Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $5K, a 25% increase year-over-year.
  • Leap Therapeutics, Inc. annual Depreciation for 2023 was $15K, a 6.25% decline from 2022.
  • Leap Therapeutics, Inc. annual Depreciation for 2022 was $16K, a 44.8% decline from 2021.
  • Leap Therapeutics, Inc. annual Depreciation for 2021 was $29K, a 14.7% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15K -$1K -6.25% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $16K -$13K -44.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $29K -$5K -14.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $34K -$13K -27.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $47K -$2K -4.08% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $49K +$1K +2.08% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $48K +$23K +92% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 $25K Jan 1, 2016 Dec 31, 2016 10-K 2018-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.